Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.AuthorsD’Angelo, Sandra P.; Hamid, Omid A.; Tarhini, Ahmad; Schadendorf, Dirk; Chmielowski, Bartosz; Collichio, Frances A.; Pavlick, Anna C.; Lewis, Karl D.; Weil, Susan C.; Heyburn, John; Schweizer, Charles; O’Shannessy, Daniel J.; Carvajal, Richard D.PublicationInvestigational New Drugs, 2018, Vol 36, Issue 1, p103ISSN0167-6997Publication typeArticleDOI10.1007/s10637-017-0530-4